Huntington Ingalls Wins Research Project With Defense Department-August 2024-www.financetom.com

Huntington Ingalls Wins Research Project With Defense Department

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Huntington Ingalls Wins Research Project With Defense Department

Oct 3, 2024 9:47 AM

12:19 PM EDT, 10/03/2024 (MT Newswires) -- Huntington Ingalls Industries ( HII ) said Thursday that its Mission Technologies division won a task order to enhance navigation and autonomy technologies for the US Department of Defense and specifically for the US Air Force.

A Huntington Ingalls team at Wright-Patterson Air Force Base in Dayton, Ohio, will conduct research for the Air Force Institute of Technology's Autonomy and Navigation Technology Center, focusing on autonomous systems, non-GPS precision navigation, and advanced navigation warfare.

Price: 260.03, Change: -1.49, Percent Change: -0.57

Previous page： Cybin Granted Additional US Patent for Potential Anxiety Disorder Treatments Next page： Chemomab Therapeutics Says Nebokitug Awarded New Patent Protections in China, Russia

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Cybin Granted Additional US Patent for Potential Anxiety Disorder Treatments

Jun 3, 2025

08:46 AM EDT, 06/03/2025 (MT Newswires) -- Cybin ( CYBN ) said Tuesday that the US Patent and Trademark Office has granted the company a patent in support of its CYB004 deuterated dimethyltryptamine program for the treatment of generalized anxiety disorder. The patent, which is expected to provide exclusivity until 2040, includes its claims to novel formulations of dimethyltryptamine and...

Chemomab Therapeutics Says Nebokitug Awarded New Patent Protections in China, Russia

Jun 3, 2025

08:39 AM EDT, 06/03/2025 (MT Newswires) -- Chemomab Therapeutics ( CMMB ) said Tuesday that China and Russia awarded new patents covering the use of its lead product nebokitug to treat liver diseases including primary sclerosing cholangitis. The patent from China protects the usage of nebokitug in hepatic diseases and provides coverage through 2038, while the patent from Russia protects...

Exclusive-China's rare earth export curbs risk halting German car production, lobby group warns

Jun 3, 2025

BERLIN (Reuters) -Germany's auto lobby warned on Tuesday that export restrictions by China on rare earths alloys, mixtures and magnets posed a serious risk to the industry and could cause production delays and outages if a solution was not found quickly. Slow granting of export licenses, as well as lags in customs clearance of exports with valid licenses, was causing...

Update: Victoria's Secret Sees Q1 Adjusted Earnings, Sales Above Analysts' Estimates

Jun 3, 2025

08:47 AM EDT, 06/03/2025 (MT Newswires) -- (Updates with security incident details, share movement starting in the fifth paragraph.) Victoria's Secret (VSCO) reported preliminary fiscal Q1 adjusted net income Tuesday of $0.09 per diluted share. Analysts polled by FactSet expected $0.04. Preliminary sales for the fiscal quarter ended May 3 were $1.35 billion. Analysts surveyed by FactSet expected $1.33 billion....